Device |
ngs whole genome sequencing for sars-cov-2 genetic analysis |
Definition |
This is an IVD test which utilizes a next generation sequencing (NGS) method performed on a high throughput sequencing platform. This test can identify and differentiate SARS-CoV-2 and support additional genetic analysis, when clinically indicated, from SARS-CoV-2-positive samples identified as positive using an EUA authorized diagnostic test. Testing is limited to designated laboratories. |
Product Code | QTA |
Device Class |
Not Classified
|
|
|